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Introduction is that SOD1
WT exerts its anti-apoptotic function by acting on the mitochondria and that mutSOD1 protein proAmyotrophic lateral sclerosis is a fatal paralytic disorder motes cell death by an aberrant mitochondrial intercharacterized by selective death of motor neurons. About action. 
3% of ALS cases are caused by mutations in the gene

, 2002). expression of the pro-apoptotic proteins Bax and Bad
To better characterize the mechanism by which SOD1 and decreased expression of the anti-apoptotic Bcl-2 regulates apoptosis and to test the models described have been found in the spinal cord of transgenic mice above, we have studied apoptotic proteins that interact expressing SOD1 with the G93A mutation (Vukosavic et with SOD1. We report here that the anti-apoptotic protein Bcl-2 interacts with both wt and mutSOD1. Moreover, we report binding of mutSOD1 to Bcl-2 in spinal and human spinal cords, Bcl-2 binds to high molecular endogenous SOD1 and that the interaction is not an artifact of overexpression of the human SOD1 protein, weight SDS-resistant mutSOD1-containing aggregates that are present in spinal cord but not liver mitochondria.
we incubated lysates from naive, nontransfected N2A cells with the anti-mouse Bcl-2 antibody. The immunoThese observations suggest the hypothesis that mutant protein captures Bcl-2 within unstable aggregates, deprecipitate was analyzed by Western blot for the presence of the endogenous mouse SOD1. Figure 1C (top) pleting the motor neurons of this anti-apoptotic protein.
shows that the anti-Bcl-2 antibody coprecipitated endogenous mouse SOD1. Bcl-2 immunoprecipitation was Results confirmed by restaining the same blot with anti-mouse Bcl-2 antibody ( Figure 1C, bottom) . This result confirms Wild-Type and Mutant SOD1 Associate with Bcl-2 the positive immunostaining for both human and mouse Postnuclear homogenates from N2A cells transfected SOD1 that we have observed in the immunoprecipitates with either the wt human SOD1 or three different mutants shown in Figure 1A and clearly shows that endogenous (G37R, G41D, and G85R) were subjected to immunopre-SOD1 associates with endogenous Bcl-2. cipitation using an anti-mouse Bcl-2 antibody. Western
To demonstrate the specificity of the interaction beblot analysis of immunoprecipitated proteins revealed tween SOD1 and Bcl-2, we performed co-immunoprethat both wt and mutSOD1s were coprecipitated by the cipitation experiments with the anti-human SOD1 antianti-mouse Bcl-2 antibody ( Figure 1A, top) , indicating a body and analyzed the resulting immunoprecipitates by physical interaction between SOD1 and Bcl-2. The N2A
Western blot with an anti-Bax and an anti-Actin antibody cells also express the endogenous mouse SOD1. Beas negative controls. Lysates from wt human SOD1-cause human SOD1 has a slower electrophoretic mobilexpressing N2A cells were immunoprecipitated for ity than mouse SOD1, the two proteins are easily distin-SOD1. Bax and Actin were not immunodetected in the guishable on Western blots. As shown in Figure 1A (top), immunoprecipitates but were present in the straight lythe anti-Bcl-2 antibody coprecipitates both the human sates ( Figure 1D) Figure 1B, left) , and SOD1 immunoprecipitation was G93A mutant SOD1 and in human spinal cord homogenates. Spinal cord homogenates from presymptomatic confirmed on the same blot restained with the antihuman SOD1 antibody ( Figure 1B, right) .
G93A ALS mice and age-matched transgenic mice overexpressing human SOD1 WT were subjected to immuTo verify that endogenous Bcl-2 can associate with and SOD1, respectively ( Figure 3B, bottom) . Western blot replicas of the second dimension showed that the 26 and the 17-20 kDa positively immunostained with the anti-mouse Bcl-2 and with the anti-SOD1 antibody, respectively ( Figure 3B, top) , confirming the results obtained by silver staining. Similar results were obtained from crosslinking of lysates of cells expressing two different SOD1 mutants (G37R and G41D) (data not shown). We cannot exclude the formal possibility that crosslinking in these experiments is between Bcl-2 or SOD1 itself; indeed, it is well established that SOD1 homodimerizes. However, these crosslinking experiments are fully consistent with complex formation between Bcl-2 and SOD1 support for this direct interaction.
SOD1
G93A mice and age-matched hSOD1 WT overexpressing mice were subjected to immunoprecipitation using the anti-mouse Bcl-2 antibody. Blots were probed with the anti-human SOD1 antibody contrast, when the Cy-3 antibody was bound to the anti-SOD1 and Bcl-2 COX4 antibody to stain the mitochondria, there was no To validate our findings, we performed crosslinking ex-FLIM-detectable association between Bcl-2 and COX4 periments followed by off-diagonal two-dimensional (2D) ( Figure 3C ). In vivo, double immunofluorescence experielectrophoresis. Lysates from human SOD1 WT -expressments revealed that SOD1 and Bcl-2 colocalize extening N2A cells were incubated with the hydrophobic sively in the anterior horn motor neurons of presympcrosslinker DSP that allows analysis of intra-and intertomatic SOD1 G93A mice (not shown). membrane interactions. DSP is a thiol-cleavable, 12 Å crosslinker routinely used in 2D nonreducing/reducing diagonal gels. In this system, DSP-linked stabilized SOD1 Directly Interacts with Bcl-2 To determine whether SOD1 directly binds to Bcl-2, we membrane complexes are first separated according to their electrophoretic mobility under nonreducing condiperformed coprecipitation experiments using in vitro translated proteins. Bcl-2 cDNA as well as SOD1 cDNAs tions. The first dimension lanes are then cut from the gel, reduced to cleave the crosslinked covalent bonds, (wt and G93A) were translated in vitro as described. Bcl-2 to the same extent. In contrast, the ⌬BH4/⌬loop Figure 5C ). that the region between the BH4 and the loop domain in Bcl-2 is required for the binding with SOD1 and that mutations in SOD1 alter this binding.
Mutant SOD1 Forms SDS-Resistant High Molecular Weight Aggregates that Preferentially To confirm that the different binding to Bcl-2 observed between wt and mutSOD1 also occurs in a cellular sysBind to Spinal Cord Mitochondria and Coprecipitate with Bcl-2 tem in which proteins are properly folded and targeted to the correct intracellular compartment, we used the We next analyzed whether mutations in SOD1 affect the interaction with Bcl-2 in vivo during disease progression Xenopus laevis oocytes expression system. Two FLAGtagged Bcl-2 mutants (⌬BH4 and ⌬BH4/⌬loop double in the SOD1 G93A mice and in human ALS. Spinal cord homogenates from either ALS mice or mice overexpressdeletion) were co-expressed in oocytes with human SOD1 (wt and G93A). When the ⌬BH4 deletion mutant ing SOD1 WT were subjected to immunoprecipitation using the anti-mouse Bcl-2 antibody. Immunoprecipitates was co-expressed with SOD1 WT , the anti-FLAG antibody was able to coprecipitate SOD1, while the ⌬BH4/⌬loop were analyzed by Western blot using the anti-human SOD1 antibody. As the disease progressed in the SOD1 G93A mice, double deletion mutant abolished or greatly reduced the interaction with SOD1 ( Figure 5B, left) . On the contrary, there was a gradual increase in the amount of SOD1 coimmunoprecipitated by the anti-Bcl-2 antibody. When when co-expressed with SOD1
G93A
, both Bcl-2 mutants compared to that of presymptomatic mice, the amount ALS patient carrying the A4V mutation. The amount of SOD1 coprecipitated by the Bcl-2 antibody is about 1.5-of SOD1 precipitated by the anti-Bcl-2 antibody is 1.8-and 2.1-fold higher at the time of onset and end stage, fold higher in the SOD1-ALS patient than in a sporadic patient and non-ALS control ( Figure 6B, left) . Moreover, respectively ( Figure 6A, histogram) . This is not due to an increase in overall SOD1 expression, since equal the anti-human Bcl-2 antibody is able to coprecipitate high molecular weight A4V-containing aggregates as SOD1 expression is detected among the different animals ( Figure 6A, upper right) . This is also not due to an observed in the mice. Bcl-2 is entrapped in these high molecular weight aggregates that stain positive for the increase over time in Bcl-2 expression, because in fact this decreases as disease progresses ( Figure 6A , lower anti-Bcl-2 antibody ( Figure 6B, right) . We next determined whether the SOD1/Bcl-2-conright; Vukosavic et al., 1999) . At the time of onset, and more at end stage, Bcl-2 binds high molecular weight taining aggregates are present in the mitochondria. Bcl-2 is a membrane protein found in mitochondria, ER, SDS-resistant SOD1 aggregates ( Figure 6A, left, asterisks) . The time course of appearance of these precipiand nuclei. A single transmembrane domain at the carboxyl terminus anchors Bcl-2 to the mitochondrial memtated aggregates and their levels of expression correlate with that of high molecular weight complexes that are brane while the majority of the protein faces the cytosol (Schimmer et al., 2001 ). Based on our in vitro experipresent in the total lysates of these mice after a prolonged exposure of the blot ( Figure 6A, lower left) . As ments with Bcl-2 deletion mutants, we predicted that while SOD1 WT binds the cytosolic portion of Bcl-2, mutshown, the high molecular weight aggregates are hardly detectable in total lysates at the time of onset. However, SOD1 binds at or near the mitochondrial membrane. A corollary prediction is that the mutSOD1 protein is the fact that they are precipitated with the Bcl-2 antibody strongly indicates that they tightly bind to Bcl-2. associated with the mitochondrion more tightly than SOD1 WT during mitochondrial purification. Accordingly, Bcl-2 binding to large mutSOD1-containing aggregates is also observed in spinal cord homogenate of an when we isolated mitochondria from mouse and human (Figures 7A and 7B) . Moreover, these gers and sustains these events has remained elusive. Equally problematic has been the explanation for how aggregated forms of mutSOD1 were pulled down with the anti-Bcl-2 antibody in spinal cord but not in liver mutations in a ubiquitously expressed and abundant protein produce a cell death process that is so exquimitochondria ( Figures 7A and 7B) . These results are not a consequence of different levels of SOD1 expression sitely motor neuron specific. in these tissues, as SOD1 is equivalently expressed in
The present study provides new insight into these spinal cord and liver mitochondria ( Figure 7C ). However, questions by delineating a direct binding interaction bethey suggest a correlation between the motor neuron tween wt or mutSOD1 and the anti-apoptotic protein phenotype of the disease and the formation of the SOD1/ Bcl-2. This interaction is readily demonstrated both Bcl-2-containing aggregates. We note that high molecuin vitro and in vivo in mouse and human spinal cords. The lar weight SDS-resistant SOD1-and Bcl-2-positive agbinding is specific; neither Actin nor the pro-apoptotic gregates similar to those in human A4V and mouse G93A protein Bax co-immunoprecipitate with SOD1. Our data spinal cord mitochondria were also detected in spinal show that ALS-associated mutSOD1 protein binds avcord mitochondria from SOD1 G37R transgenic ALS mice idly to mitochondria with which it forms SDS-resistant (Supplemental Figure S1 at http://www.neuron.org/cgi/ aggregates that, in turn, are bound by and contain Bcl-2. content/full/43/1/19/DC1).
We also report comparable association between SOD1/ Bcl-2-positive aggregates and mitochondria in the spinal cord of a patient who succumbed to familial ALS Discussion caused by the very common alanine-4-valine mutation. In our view, it is striking that both in the ALS mice and In transgenic ALS mice, it is evident that multiple pro-FALS-A4V patient, these SOD1/Bcl-2-containing aggrecesses converge to reduce motor neuron viability in an gates are readily detected in spinal cord mitochondria age-dependent manner. As gauged temporally, these but are absent in liver mitochondria. These observations include early mitochondrial vacuolization (Wong et to Bcl-2 but do not find evidence that the wt molecule to the presence of mutSOD1 has been confirmed in is present in isolated mitochondria. We think that this quantitative estimates of cell death arising from tardiscrepancy reflects differences in our assays. Because geting of SOD1 specifically to the nucleus, cytosol, and our detection system required immunoprecipitation, we mitochondrion (Takeuchi et al., 2002) .
should have detected even minute amounts of residual The mechanism for the particular susceptibility of mi-SOD1 WT in the purified mitochondria. The failure to do tochondria to mutSOD1 has not been explained. An imso strongly suggests that SOD1 WT is not present in the portant clue is provided by several studies in the last isolated mitochondrion. It is conceivable that less strinfive years showing that in yeast, mice, and rats, a fraction gent systems for the purification of the mitochondrion of the normally cytosolic SOD1 protein is detected within and detection of the SOD1/Bcl-2 interaction may entail the mitochondrion, probably either at the surface of this residual contamination by cytosolic SOD1. organelle or within its intermembrane space (Sturtz et How do that SOD1 WT binds the cytosolic portion of Bcl-2. In vivo, Members of the Bcl-2 family regulate apoptosis either the ionic strength of the mitochondria isolation buffer is through homodimerization, heterodimerization with prosufficient to disrupt this binding. On the contrary, the teins in the same family, or binding with other protein binding between mutSOD1 and Bcl-2 is stable in the partners. One possible consequence of the binding of same buffer. Moreover, our data suggest that mutSOD1 Bcl-2 to SOD1 may be that Bcl-2 itself will effectively be does not exclusively bind the N terminus. Because we entrapped and rendered nonfunctional as the mutSOD1 find mutSOD1 in the purified, isolated mitochondria, we protein aggregates. To the extent that Bcl-2 also actively believe that the mutated protein binds the carboxy-terbinds other anti-apoptotic proteins, this process of segminal domain of Bcl-2. Whether such docking is required regation may further render the mitochondrion and its for subsequent translocation into the mitochondrion and host cell less viable. This proposal is analogous to the the mechanism of translocation are not known. Okadosuggestion that aggregated SOD1 might serve as a sink Matsumoto and Fridovich reported that in mouse neurofor heat shock proteins, thereby increasing the pro-apoblastoma N2A cells, the entry of both wt and mutSOD1 ptotic state of the mitochondrion (Okado-Matsumoto into the mitochondria depends on demetallation. While and Fridovich, 2002). Entrapment of Bcl-2 into mutSOD1 partially or fully demetallated SOD1 is integrated into aggregates may also inhibit heterodimerization of Bcl-2 the mitochondrion, the holoenzyme is not. Noted in this with pro-apoptotic molecules, a process that normally context are reports that demetallation of mutSOD1 acblocks apoptosis. We note that in isolated mitochondria centuates its neurotoxic properties in neurons in vitro from the spinal cord of an A4V ALS patient, coprecipi- The ⌬BH4 Bcl-2 deletion mutant and the ⌬BH4/⌬loop Bcl-2 double beads (Qiagen, Valencia, CA). Rabbit anti-mouse Bcl-2 primary antideletion mutant were subcloned into a pCMV-Tg4 vector (Strabody (2.5 g) or rabbit anti-human SOD1 primary antibody (5 g) tagene) containing a N-terminal FLAG and transcribed in vitro using were then added to the lysates and incubated overnight at 4ЊC. the mMessage mMachine Kit (Ambion). Linearized human SOD1 (wt The antibody-antigen complex was then precipitated with Protein and mutants) containing plasmids were similarly transcribed. Stage A magnetic beads (4 hr, 4ЊC, with rotation). Immunoprecipitates V Xenopus laevis oocytes were enzymatically defolliculated, injected were washed three times with 200 l of RIPA buffer, 20 l of reducing with bcl-2 cRNAs (20 ng/50 nl/oocyte) in combination with wt or sample buffer were added to the final pellet, and samples were mutSOD1 cRNAs (20 ng/50 nl/oocyte), and maintained at 18ЊC in boiled. Beads were pulled down using a magnet, supernatant was L-15 solution (Specialty Media) supplemented with gentamycin sulloaded on a 15% SDS-PAGE for electrophoresis, and Western blot fate (100 g/ml). 3 days postinjection, oocytes were solubilized in analysis was followed by enhanced chemiluminescence using the RIPA buffer containing protease inhibitors; human Bcl-2 and human Amersham ECL system. SOD1 were co-immunoprecipitated using a monoclonal anti-FLAG For immunoprecipitation of mouse or human spinal cord, samples antibody (Stratagene). Proteins were resolved on SDS-PAGE, transwere homogenized in RIPA buffer containing protease inhibitors and ferred to nitrocellulose, and analyzed by Western immunoblotting. immunoprecipitation was carried out as described above. In the human samples, an anti-human Bcl-2 antibody was used.
Mitochondria Isolation Mouse and human liver and spinal cord were homogenized in Buffer Crosslinking Analysis and Two-Dimension Electrophoresis
A containing 70 mM sucrose, 190 mM mannitol, 20 mM HEPES, and The hydrophobic crosslinker DSP (Pierce, Rockford, IL; 5 mg/ml in 0.2 mM EDTA (pH 7.5) in a glass-Teflon pestle. The homogenate DMSO) was used. 1 mg of N2A cell lysates were incubated for 30 was centrifuged at 650 ϫ g for 10 min. The resulted supernatant min at room temperature with 0, 0.5, or 2 mM DSP in a final volume was centrifuged at 7700 ϫ g for 10 min. The resulted supernaof 500 l, buffered with PBS (pH 7.4). The reaction was stopped tant was centrifuged at 100,000 ϫ g to collect the cytosolic fraction with 1 M Tris-HCl, and 500 l of 2ϫ nonreducing sample buffer were while the pellet was resuspended in Buffer A and centrifuged again added to each sample. Samples were boiled for 10 min prior to at 7700 ϫ g for 10 min. The resulting mitochondrial pellet was resusanalysis in the first dimension SDS-PAGE. The position of high mopended in 200 l of immunoprecipitation buffer containing protelecular mass complexes was analyzed in the first dimension by ase inhibitors. Western blot analysis using antibodies to either mouse Bcl-2 or human SOD1. First dimension lanes were excised from unstained, unfixed gels, reduced in ␤-mercapto-ethanol, and laid on top of the Acknowledgments second dimension SDS-PAGE and proteins resolved under reducing conditions. Gels were silver stained using a GelCode SilverSNAP
We 
